Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 08 May 2019
Price : $35 *
At a glance
- Drugs 18F DCFPyL (Primary) ; Imaging agents; Sodium fluoride
- Indications Prostate cancer
- Focus Diagnostic use
- 02 May 2019 Planned End Date changed from 1 May 2021 to 1 Nov 2020.
- 02 May 2019 Planned primary completion date changed from 1 May 2021 to 1 Nov 2020.
- 17 Apr 2018 New trial record